Cover Image
市場調查報告書

全球生技仿製藥市場分析

Analysis of the Global Biosimilars Market

出版商 Frost & Sullivan 商品編碼 293861
出版日期 內容資訊 英文 380 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球生技仿製藥市場分析 Analysis of the Global Biosimilars Market
出版日期: 2014年01月16日 內容資訊: 英文 380 Pages
簡介

專利失效即將發生,下一代的生技仿製藥的平台,成為成長的原動力。

本報告提供全球生技仿製藥市場相關調查分析、地區的市場普及率與市場動態焦點、市場概要、市場工程評量、收益預測、競爭分析、市場/各市場區隔的主要趨勢,為您概述為以下內容。

本調查涵蓋內容

  • 全球生技仿製藥市場目前方案為何?預計繼續到什麼時候?
  • 市場主要推動因素為何?應該解決的障礙為何?
  • 受到關注市場市場區隔為何?主要趨勢與法規方面為何?
  • 主要打入市場企業為何?地區為何?
  • 歐洲的各地區的影響市場的要素為何?
  • 未來的生技仿製藥市場情況為何?為了在市場能成功參與企業應該做事為何?

目錄

  • 摘要整理
  • 市場概要
  • 競爭情形
  • 推動因素、阻礙因素、趨勢:綜合市場
  • 預測與趨勢:綜合市場
  • 競爭環境
  • 值得注意的主要企業
  • 歐洲市場
  • 歐洲:促血紅細胞生長素
  • 歐洲:顆粒細胞增生因子
  • 歐洲:人體生長荷爾蒙
  • 歐洲:胰島素
  • 歐洲:單株抗體
  • 歐洲:干擾素
  • 英國市場
  • 德國市場
  • 法國市場
  • 義大利市場
  • 西班牙市場
  • 荷比盧三國市場
  • 斯堪地那維亞市場
  • 美國市場
  • 美國:促血紅細胞生長素
  • 美國:顆粒細胞增生因子
  • 美國:人體生長荷爾蒙
  • 美國:胰島素
  • 美國:單株抗體
  • 美國:干擾素
  • 中國市場
  • 中國:促血紅細胞生長素
  • 中國:顆粒細胞增生因子
  • 中國:人體生長荷爾蒙
  • 中國:胰島素
  • 中國:單株抗體
  • 中國:干擾素
  • 印度市場
  • 韓國市場
  • 日本市場
  • 澳洲市場
  • 南美市場
  • 南美:促血紅細胞生長素
  • 南美:顆粒細胞增生因子
  • 南美:人體生長荷爾蒙
  • 南美:胰島素
  • 南美:單株抗體
  • 南美:干擾素
  • 巴西市場
  • 墨西哥市場
  • 阿根廷市場
  • 彙整
  • 附錄

圖表

目錄
Product Code: M95E-01-00-00-00

Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth

Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market. The research service provides analysis on regional market penetration and market dynamics. This study also provides a market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the biosimilars market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia as well as Asia-Pacific and Latin America. The study period is 2009-2019, with 2012 as the base year.

Key Questions This Study Will Answer

  • What is the current scenario of the global biosimilars market, and how far will it go?
  • What are the key factors driving the market, and what are the barriers that need to be resolved?
  • Which are the key market segments to look out for, and what are the key trends and regulatory aspects?
  • Who are the key market participants involved, and where do they stand?
  • What are the factors affecting the biosimilars market in different regions of Europe, and how will these factors affect the market in the future?
  • What is the future biosimilars market scenario, and what should market participants do to succeed?

Table of Contents

1. Executive Summary

  • Key Findings
  • Scope and Segmentation
  • Key Questions This Study Will Answer
  • Market Engineering Measurements
  • CEO's Perspective
  • Key Companies to Watch
  • Executive Summary-3 Big Predictions

2. Market Overview

  • Comparative Analysis: Generics, Biosimilars, and Biologics
  • Market Segmentation
  • Geographic Perspective
  • Timeline of Key Events
  • Biosimilar Trends in the Future

3. Competitive Playbook

  • New Market Opportunities
  • Merger, Acquisition, and Partnership Assessment

4. Drivers, Restraints, and Trends-Total Biosimilars Market

  • Market Drivers
  • Market Restraints
  • Impact Mapping of Drivers and Restraints

5. Forecasts and Trends-Total Biosimilars Market

  • Market Engineering Measurements
  • Forecast Assumptions and Definitions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Percent Revenue Forecast by Region
  • Revenue Forecast by Region
  • Emerging Trends-Biobetters

6. Competitive Environment

  • Competitive Landscape Analysis
  • Pipeline Analysis
  • Market Share Analysis-Global

7. Key Companies to Watch

  • Companies to Watch

8. Europe Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Market Analysis
  • Pricing Analysis
  • Pricing Trends and Forecast
  • PEST Analysis
  • Market Share Analysis
  • Marketed Product Analysis
  • Biologics Patent Expiry Analysis
  • Patent Expirations

9. Europe Erythropoietin Segment Breakdown

10. Market Overview

  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Regulatory Environment-Europe EPO Biosimilars

11. Europe Granulocyte Colony Stimulating Factors Segment Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Regulatory Environment-Europe G-CSF Biosimilars

12. Europe Human Growth Hormone Segment Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Regulatory Environment-Europe HGH Biosimilars

13. Europe Insulin Segment Breakdown

  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion
  • Regulatory Environment-Europe Insulin Biosimilars

14. Europe Monoclonal Antibodies Segment Breakdown

  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion
  • Regulatory Environment-Europe mAbs Biosimilars

15. Europe Interferons Segment Breakdown

  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion
  • Regulatory Environment-Europe Interferon Biosimilars

16. The United Kingdom Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

17. Germany Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

18. France Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

19. Italy Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

20. Spain Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

21. Benelux Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

22. Scandinavia Breakdown

  • Market Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion

23. The United States Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Pricing Analysis
  • PEST Analysis
  • Biologics Patent Expiry Analysis
  • Patent Expirations

24. The United States Erythropoietin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

25. The United States Granulocyte Colony Stimulating Factors Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

26. The United States Human Growth Hormone Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Trends and Forecast
  • Pricing Trends and Forecast Discussion

27. The United States Insulin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

28. The United States Monoclonal Antibodies Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Scenario Revenue Forecast
  • Scenario Revenue Forecast Discussion

29. The United States Interferons Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Trends and Forecast
  • Pricing Trends and Forecast Discussion

30. China Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • PEST Analysis
  • Regulatory Environment
  • Market Share Analysis

31. China Erythropoietin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

32. China Granulocyte Colony Stimulating Factors Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

33. China Human Growth Hormone Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

34. China Insulin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

35. China Monoclonal Antibodies Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Local Market Participants

36. China Interferons Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pricing Analysis
  • Local Market Participants

37. India Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • PEST Analysis

38. South Korea Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Reimbursement System and Pricing Analysis
  • PEST Analysis
  • Marketed Product Analysis
  • Pipeline Analysis

39. Japan Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Pricing Analysis
  • Pricing Trends and Forecast
  • PEST Analysis
  • Product Analysis

40. Australia Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Pricing Analysis
  • Pricing Trends and Forecast
  • PEST Analysis

41. Latin America Breakdown

  • Market Overview-Biosimilars
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis
  • Regulatory Environment
  • Pricing Analysis
  • Pricing Trends and Forecast
  • Pricing Trends and Forecast Discussion
  • PEST Analysis
  • Competitive Analysis

42. Latin America Erythropoietin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

43. Latin America Granulocyte Colony Stimulating Factors Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

44. Latin America Human Growth Hormone Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

45. Latin America Insulin Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

46. Latin America Monoclonal Antibodies Segment Breakdown

  • Market Overview

47. Latin America Interferons Segment Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion

48. Brazil Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis

49. Mexico Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis

50. Argentina Breakdown

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Analysis

51. The Last Word

  • The Last Word-3 Big Predictions
  • The Last Word-Discussion
  • Legal Disclaimer

52. Appendix

  • Market Overview
  • Market Definitions
  • Market Background
  • Drivers Explained
  • Restraints Explained
  • Market Engineering Methodology
  • Learn More-Next Steps
  • Decision Support Databases

List of Exhibits

  • Total Biosimilars Market: Market Engineering Measurements, Global, 2012
  • Comparative Analysis: Generics, Biosimilars, and Biologics, Global, 2012
  • Total Biosimilars Market: Market Segmentation, Global, 2012
  • Total Biosimilars Market: Percent Revenue by Geographic Region, Global, 2012
  • Total Biosimilars Market: Timeline of Key Events, Global, 2012 and 2013
  • Total Biosimilars Market: Market Outlook, Global, 2012 and 2022
  • Total Biosimilars Market: Game-changing Strategies, Global, 2012
  • Total Biosimilars Market: Market Outlook, Global, 2012
  • Total Biosimilars Market: Key Market Drivers, Global, 2013-2019
  • Total Biosimilars Market: Key Market Restraints, Global, 2013-2019
  • Total Biosimilars Market: Impact Mapping of Drivers and Restraints, Global, 2013-2019
  • Total Biosimilars Market: Market Engineering Measurements, Global, 2012
  • Total Biosimilars Market: Revenue Forecast, Global, 2009-2019
  • Total Biosimilars Market: Percent Revenue Forecast by Region, Global, 2009-2017
  • Total Biosimilars Market: Revenue Forecast by Region, Global, 2009-2019
  • Total Biosimilars Market: Competitive Landscape Analysis, Global, 2012
  • Total Biosimilars Market: Pipeline Analysis, Global, 2012
  • Total Biosimilars Market: Competitive Landscape, Global, 2012
  • Total Biosimilars Market: Percent Sales Breakdown, Global, 2012
  • Total Biosimilars Market: Company Market Share Analysis of Top 5 Participants, Global, 2012
  • Biosimilars Market: Key Stake Holders, Europe, 2012
  • Biosimilars Market: Market Engineering Measurements, Europe, 2012
  • Biosimilars Market: Revenue Forecast, Europe, 2009-2019
  • Biosimilars Market: Pricing Analysis, Europe, 2012
  • Biosimilars Market: Time from Marketing Authorisation to Price Approval, Europe, 2012
  • Biosimilars Market: Average Price for EPO, Europe, 2009-2019
  • Biosimilars Market: Average Price for G-CSF, Europe, 2009-2019
  • Biosimilars Market: Average Price for HGH, Europe, 2009-2019
  • Biosimilars Market: PEST Analysis, Europe, 2012
  • Biosimilars Market: Percent of Sales, Europe, 2012
  • Biosimilars Market: Company Market Share Analysis of Top 5 Participants, Europe, 2012
  • Biosimilars Market: Ranking of Key Participants Based on Market Share, Europe, 2012
  • Biosimilars Market: Competitive Landscape, Europe, 2012
  • Biosimilars Market: Marketed Product Analysis, Europe, 2012
  • Biologics Market: Patent Expiry Analysis, Europe, 2012
  • Biologics Market: Patent Expirations, Europe, 2000-2030
  • EPO Segment: Market Engineering Measurements, Europe, 2012
  • EPO Segment: Revenue Forecast, Europe, 2009-2019
  • G-CSF Segment: Market Engineering Measurements, Europe, 2012
  • G-CSF Segment: Revenue Forecast, Europe, 2009-2019
  • HGH Segment: Market Engineering Measurements, Europe, 2012
  • HGH Market: Revenue Forecast, Europe, 2009-2019
  • Insulin Segment: Scenario Revenue Forecast, Europe 2015-2019
  • mAbs Segment: Scenario Revenue Forecast, Europe 2015-2019
  • Interferons Segment: Scenario Revenue Forecast, Europe 2015-2019
  • Biosimilars Market: Market Engineering Measurements, UK, 2012
  • Biosimilars Market: Revenue Forecast, UK, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Germany, 2012
  • Biosimilars Market: Revenue Forecast, Germany, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, France, 2012
  • Biosimilars Market: Revenue Forecast, France, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Italy, 2012
  • Biosimilars Market: Revenue Forecast, Italy, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Spain, 2012
  • Biosimilars Market: Revenue Forecast, Spain, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Benelux, 2012
  • Biosimilars Market: Revenue Forecast, Benelux, 2009-2019
  • Biosimilars Market: Market Engineering Measurements, Scandinavia, 2012
  • Biosimilars Market: Revenue Forecast, Scandinavia, 2009-2019
  • Biosimilars Market: Revenue Forecast, US, 2009-2019
  • Biosimilars Market: Revenue Forecast Comparison between Branded Biologics and Biosimilars, US, 2009-2019
  • Biosimilars Market: Timeline of Biosimilars Regulatory Activity, US, 2012
  • Biosimilars Market: Overview of Application Requirements for Biosimilars, US, 2012
  • Biosimilars Market: Biosimilars User Fee Act Fee Structure, US, 2012
  • Biosimilars Market: Pricing Analysis, US, 2012
  • Biosimilars Market: PEST Analysis, US, 2012
  • Biologics Market: Patent Expiry Analysis, US, 2012
  • Biologics Market: Patent Expirations, US, 2000-2030
  • EPO Segment: Revenue Forecast, US, 2009-2019
  • EPO Segment: Scenario Revenue Forecast, US, 2009-2019
  • EPO Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • EPO Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • EPO Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • G-CSF Segment: Revenue Forecast, US, 2009-2019
  • G-CSF Segment: Scenario Revenue Forecast, US, 2009-2019
  • G-CSF Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • G-CSF Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • G-CSF Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • HGH Segment: Revenue Forecast, US, 2009-2019
  • HGH Segment: Revenue Forecast Comparison Between Branded Biologics and Biosimilars, US, 2009-2019
  • HGH Segment: Annual Cost of Therapy, US, 2009-2019
  • HGH Segment: ACT Comparison Between Branded Biologics and Biosimilars, US, 2009-2019
  • Insulin Segment: Revenue Forecast, US, 2009-2019
  • Insulin Segment: Scenario Revenue Forecast, US, 2009-2019
  • Insulin Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • Insulin Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • Insulin Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • mAbs Segment: Revenue Forecast, US, 2009-2019
  • Biosimilars Market: Marketed mAbs at Risk for Biosimilar Competition, US, 2012
  • mAbs Segment: Scenario Revenue Forecast, US, 2015-2019
  • mAbs Segment: Optimistic Scenario-Revenue Forecast, US, 2015-2019
  • mAbs Segment: Frost & Sullivan Scenario-Revenue Forecast, US, 2015-2019
  • mAbs Segment: Conservative Scenario-Revenue Forecast, US, 2015-2019
  • Interferons Segment: Revenue Forecast, US, 2009-2019
  • Interferons Segment: Annual Cost of Therapy, US, 2009-2019
  • Interferons Segment: ACT Comparison Between Branded Biologics and Biosimilars, US, 2009-2019
  • Biosimilars Market: Revenue Forecast, China, 2009-2019
  • Biosimilars Market: PEST Analysis, China,2012
  • Biosimilars Market: Percent of Sales, China, 2012
  • EPO Segment: Revenue Forecast, China, 2009-2019
  • EPO Segment: Pricing Analysis, China, 2012
  • G-CSF Segment: Revenue Forecast, China, 2009-2019
  • G-CSF Segment: Pricing Analysis, China, 2012
  • HGH Segment: Revenue Forecast, China, 2009-2019
  • HGH Segment: Pricing Analysis, China, 2012
  • Insulin Segment: Revenue Forecast, China, 2009-2019
  • Insulin Segment: Pricing Analysis, China, 2012
  • mABs Segment: Revenue Forecast, China, 2009-2019
  • Interferons Segment: Revenue Forecast, China, 2009-2019
  • Interferons Segment: Pricing Analysis, China, 2012
  • Biosimilars Market: Revenue Forecast, India, 2009-2019
  • Biosimilars Market: PEST Analysis, India, 2012
  • Biosimilars Market: Revenue Forecast, South Korea, 2009-2019
  • Biosimilars Market: Regulatory Guidelines, South Korea, 2012
  • Biosmilar Market: PEST Analysis, South Korea, 2012
  • Biosimilars Market: Pipeline Analysis, South Korea, 2012
  • Biosimilars Market: Revenue Forecast, Japan, 2009-2019
  • Biosimilars Market: Regulatory Guidelines, Japan, 2012
  • Biosimilars Market: Pricing Analysis, Japan, 2012
  • Biosimilars Market: Average Price for G-CSF, Japan, 2009-2019
  • Biosimilars Market: Average Price for EPO, Japan, 2009-2019
  • Biosimilars Market: PEST Analysis, Japan, 2012
  • Biosimilars Market: Product Analysis, Japan, 2012
  • Biosimilars Market: Revenue Forecast, Australia, 2009-2019
  • Biosimilars Market: Pricing Analysis, Australia, 2012
  • Biosimilars Market: PEST Analysis, Australia, 2012
  • Biosimilars Market: Revenue Breakdown by Segment, Latin America, 2012
  • Biosimilars Market: Revenue Forecast, Latin America, 2009-2019
  • Biosimilars Market: Pricing Analysis, Latin America, 2012
  • Biosimilars Market: Average Price for G-CSF, Latin America, 2009-2019
  • Biosimilars Market: Average Price for HGH, Latin America, 2009-2019
  • Biosimilars Market: Average Price for Insulin, Latin America, 2009-2019
  • Biosimilars Market: Average Price for Interferons, Latin America, 2009-2019
  • Biosimilars Market: PEST Analysis, Latin America, 2012
  • Biosimilars Market: Top Biosimilar Companies by Rank, Latin America, 2012
  • EPO Segment: Revenue Forecast, Latin America, 2009-2019
  • G-CSF Segment: Revenue Forecast, Latin America, 2009-2019
  • HGH Segment: Revenue Forecast, Latin America, 2009-2019
  • Insulin Segment: Revenue Forecast, Latin America, 2009-2019
  • Interferons Segment: Revenue Forecast, Latin America, 2009-2019
  • Biosimilars Market: Revenue Forecast, Brazil, 2009-2019
  • Biosimilars Market: Revenue Forecast, Mexico, 2009-2019
  • Biosimilars Market: Revenue Forecast, Argentina, 2009-2019
  • Total Biosimilars Market: Pharma Industry and Biosimilar Trends Market, Global, 2012
  • Pharmaceutical and Biotech Industry: Revenue Forecast, Global, 2009-2019
  • Decision Support Database: Total Pharmaceutical Market, Global, 2008-2018
  • Decision Support Database: Pharmaceutical R&D Expenditure, Global, 2008-2018
  • Decision Support Database: Number of Biotech Companies, Global, 2008-2018
  • Decision Support Database: Government R&D Expenditure in Biotechnology, Global, 2008-2018
  • Decision Support Database: Venture Capital Investment in Biotech R&D, Global, 2008-2018
Back to Top